ストックスクリーナーアプリを入手
211.83
1.10%
2.30
アフターアワーズ：
211.83
前日終値:
$209.53
開ける：
$211.65
24時間の取引高:
1.01M
Relative Volume:
0.84
時価総額：
$29.54B
収益：
$2.12B
当期純損益:
$-309.19M
株価収益率:
-92.74
EPS:
-2.2841
ネットキャッシュフロー:
$93.57M
1週間 パフォーマンス:
-1.72%
1か月 パフォーマンス:
-12.31%
6か月 パフォーマンス:
+30.38%
1年 パフォーマンス:
+35.79%
1日の値動き範囲:
$209.02
$214.39
1週間の範囲:
$207.01
$218.50
52週間の値動き範囲:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
211.83 | 29.22B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
513.68 | 193.72B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
209.52 | 147.88B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
657.38 | 51.84B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.72 | 35.19B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.44 | 32.01B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 開始されました | Citigroup | Buy |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-10-27 | アップグレード | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 再開されました | Wells Fargo | Equal Weight |
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
Assessing Natera (NTRA) Valuation After Positive SINERGY Trial Results In Head And Neck Cancer - simplywall.st
A Preview Of Natera's Earnings - Benzinga
Natera says Phase 2 SINERGY trial met primary endpoint - TipRanks
Natera Earnings: What To Look For From NTRA - Finviz
Natera (NTRA) Reports Success in SINERGY Trial for Head and Neck Cancer - GuruFocus
Chemo cut by two-thirds with ctDNA-guided care in head and neck cancer study - Stock Titan
Is Natera (NTRA) Fairly Priced After Recent Share Price Pullback? - Yahoo Finance
How Surging Signatera Oncology Volumes At Natera (NTRA) Have Changed Its Investment Story - simplywall.st
Justices Want Natera's Take On CareDx's False Ad Petition - Law360
Natera, Inc. (NTRA) Stock Analysis: High Growth Potential With 21.25% Upside - DirectorsTalk Interviews
Aug Highlights: Is Natera Inc stock forming a triangle patternJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - baoquankhu1.vn
Unveiling Natera (NTRA) Q4 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance
Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks - The Motley Fool
Vanguard Group Inc. Sells 287,620 Shares of Natera, Inc. $NTRA - MarketBeat
How does Natera Inc. compare to its peers2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - mfd.ru
Cibc World Market Inc. Sells 6,191 Shares of Natera, Inc. $NTRA - MarketBeat
Will Natera Inc. stock reach all time highs in 2025New Guidance & Daily Technical Stock Forecast Reports - mfd.ru
CtDNA Detection Market Set to Witness Massive Growth by 2033: Key Players • Roche • Biocept • Natera • Illumina - openPR.com
Natera targets ex-employee over mass file download before rival move - Life Sciences Intellectual Property Review
Natera (NTRA) to Release Earnings on Thursday - MarketBeat
Assessing Natera (NTRA) Valuation After Launch Of EDEN Preeclampsia Risk Study - simplywall.st
Natera Accuses Worker Who Went to Competitor of Stealing Secrets - Bloomberg Law News
Analysts Offer Insights on Healthcare Companies: American Well (AMWL), Centene (CNC) and Natera (NTRA) - The Globe and Mail
Natera, Inc. $NTRA Shares Sold by Eagle Health Investments LP - MarketBeat
Readystate Asset Management LP Invests $12.74 Million in Natera, Inc. $NTRA - MarketBeat
Piper Sandler reiterates Natera stock rating on Japan expansion By Investing.com - Investing.com South Africa
CareDx gets $96M jury verdict overturned in Natera patent dispute - MSN
Piper Sandler reiterates Natera stock rating on Japan expansion - Investing.com
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026 - Yahoo Finance
Zweig DiMenna Associates LLC Buys 8,400 Shares of Natera, Inc. $NTRA - MarketBeat
JPMorgan Chase & Co. Buys 1,003,129 Shares of Natera, Inc. $NTRA - MarketBeat
Natera's Signatera test to be covered under Medicare - MSN
Natera, Inc. (NTRA) Stock Analysis: Unpacking the 24.72% Potential Upside in the Diagnostics Powerhouse - DirectorsTalk Interviews
Natera, Inc. (NTRA) reports preliminary Q4 revenue - MSN
How (NTRA) Movements Inform Risk Allocation Models - Stock Traders Daily
CareDx Seeks High Court Review Of $45M False Ad Case - Law360
Prenatal Testing Co. Missed Fatal Condition, Couple Say - Law360
MSN Money - MSN
Krilogy Financial LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Allspring Growth Fund Q4 2025 Fund Performers And Detractors - Seeking Alpha
Envestnet Asset Management Inc. Purchases 17,254 Shares of Natera, Inc. $NTRA - MarketBeat
How Natera Inc. stock trades before earnings2025 Dividend Review & Real-Time Buy Signal Notifications - mfd.ru
Natera Inc (NTRA) Trading 3.93% Higher on Feb 9 - GuruFocus
When Will Natera, Inc. (NASDAQ:NTRA) Breakeven? - 富途牛牛
Earnings Miss: What are analysts price targets for Natera Inc2025 Market Overview & Pattern Based Trade Signal System - baoquankhu1.vn
Natera, Inc. $NTRA Shares Sold by Savant Capital LLC - MarketBeat
Is Natera (NTRA) Quietly Redefining Its Moat With Multi-Front Cell-Free DNA Expansion? - simplywall.st
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes - Yahoo Finance
AGF Management Ltd. Sells 6,300 Shares of Natera, Inc. $NTRA - MarketBeat
This brand-new Peninsula building sat vacant for a year. Now it's landed two big tenants - The Business Journals
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
0.02%
2.10%
大文字化:
|
ボリューム (24 時間):